MARY MACMILLAN, R.PH.
Oncology Pharmacist in HONOLULU, Hawaii. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: MARY MACMILLAN, R.PH. specializes in Oncology Pharmacist and practices in HONOLULU, Hawaii, listed in the federal CMS National Provider Identifier registry. Every detail on this page comes straight from federal CMS records, with no proprietary rating applied.
MARY MACMILLAN, R.PH. at a glance
Quality data not reportedPrimary specialty
Specialty distribution in Hawaii
How Oncology Pharmacist compares to other specialties among Hawaii providers
Oncology Pharmacist share within Hawaii
Oncology Pharmacist is one of the more visible NUCC categories in Hawaii
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Oncology Pharmacist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Oncology Pharmacist ABMS/AOA estimate
Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Oncology Pharmacist US NPIs
Specialty board-certified rate — Oncology Pharmacist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARY MACMILLAN, R.PH. is a Oncology Pharmacist provider practicing in HONOLULU, Hawaii, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: R.PH.. NPI: 1053485144. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
MARY MACMILLAN, R.PH. appears in the CMS NPPES registry as a Oncology Pharmacist provider holding R.PH. credentials at 3288 MOANALUA RD, HONOLULU, HI, 96819, with a listed phone of (808) 423-8593. NPI 1053485144 was issued on 11/20/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MACMILLAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D prescribing data is not currently published for this NPI, which typically means the provider either wrote fewer than 11 Part D claims in the most recent reporting year, does not participate in Medicare, or practices in a specialty that rarely prescribes outpatient drugs. Absence of prescribing data is not a quality signal — many Oncology Pharmacist providers operate outside Part D entirely.
Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1053485144 |
|---|---|
| Specialty | Oncology Pharmacist |
| Credentials | R.PH. |
| Gender | Female |
| NPI Issued | 11/20/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARY MACMILLAN, R.PH.'s current license status, disciplinary history, and board certifications with the Hawaii Medical Board in Hawaii before relying on this page for a clinical or care decision.
How we sourced this profile
Oncology Pharmacist Overview
How MARY MACMILLAN, R.PH. fits within the Oncology Pharmacist landscape nationally.
Nearby Oncology Pharmacist Providers in Hawaii
Other clinicians with the same primary specialty enrolled in Hawaii, drawn from the same CMS NPPES roster as MACMILLAN.
Compare Oncology Pharmacist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Hawaii
Frequently Asked Questions
What is MARY MACMILLAN, R.PH.'s specialty? ▼
Where is MARY MACMILLAN, R.PH. located? ▼
What is MARY MACMILLAN, R.PH.'s NPI number? ▼
How many Oncology Pharmacist providers are there in the US? ▼
Does MARY MACMILLAN, R.PH. accept Medicare? ▼
How can I verify MARY MACMILLAN, R.PH.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology